Local Institution

Volgograd 400138

0 studies enrolling now · 8 studies all time

What they study most

Bipolar Disorder, Chronic Hepatitis C Infection, Diabetes, Hepatitis C Virus (HCV), Hepatitis C, Genotype 1, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV — Stopped early
• An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets — Completed
• Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes — Completed
• Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus — Completed
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• Study of Aripiprazole in Patients With Acute Bipolar Mania — Completed
• Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C — Withdrawn before enrolling